The upregulation of IL-4 not only increased the expression of PD-L1 in breast cancer cells but also promoted the expression of PD-L1 in M2 macrophages, allowing for immune escape from breast cancer (Zheng et al., 2022). Here, IL4 is linked to breast carcinoma.